Share Price and Basic Stock Data
Last Updated: November 4, 2025, 4:08 pm
| PEG Ratio | 2.86 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Esab India Ltd operates in the welding equipment industry, with a current stock price of ₹4,986 and a market capitalization of ₹7,674 Cr. The company reported a steady revenue growth trajectory, with sales rising from ₹896 Cr in FY 2022 to ₹1,091 Cr in FY 2023, and further to ₹1,243 Cr in FY 2024. The trailing twelve months (TTM) revenue stood at ₹1,396 Cr, indicating a robust demand for its products. Quarterly sales figures reflect this trend, with sales recorded at ₹302 Cr in March 2023 and increasing to ₹341 Cr by March 2024. The company has exhibited resilience in maintaining revenue growth despite economic fluctuations, supported by a diversified product portfolio and a strong brand presence in the market.
Profitability and Efficiency Metrics
Esab India Ltd has demonstrated impressive profitability metrics, with a reported operating profit margin (OPM) of 17% and a net profit of ₹172 Cr. The return on equity (ROE) was recorded at 52.3%, while the return on capital employed (ROCE) stood at a remarkable 70%. These figures highlight the company’s ability to generate substantial returns on shareholder investments and its effective use of capital. The interest coverage ratio (ICR) of 150.19x indicates robust financial health, with the company comfortably covering its interest expenses. However, the operating profit margin has shown slight fluctuations, reflecting potential cost pressures. Despite this, the company maintains strong profitability, supported by effective cost management strategies.
Balance Sheet Strength and Financial Ratios
Esab India’s balance sheet reflects a strong financial position, with total reserves amounting to ₹346 Cr against borrowings of only ₹4 Cr. This low leverage underscores the company’s prudent financial management and ability to fund operations without relying heavily on debt. The price-to-book value (P/BV) ratio stood at 19.37x, indicating a premium valuation in comparison to typical sector norms. The company’s current ratio of 1.74x and quick ratio of 1.26x suggest adequate liquidity to meet short-term obligations. Additionally, the asset turnover ratio of 2.29x highlights efficient asset utilization. However, the high P/BV ratio may raise concerns about overvaluation, particularly if earnings growth does not keep pace with market expectations.
Shareholding Pattern and Investor Confidence
Esab India Ltd’s shareholding pattern indicates strong promoter confidence, with promoters holding 73.72% of the equity. The presence of institutional investors is moderate, with foreign institutional investors (FIIs) at 1.53% and domestic institutional investors (DIIs) at 12.77%. The number of shareholders has grown to 21,499, reflecting increasing public interest and confidence in the company. The dividend payout ratio stands at 68.43%, indicating a commitment to returning profits to shareholders while retaining sufficient earnings for growth. Despite the relatively low FII participation, the stable promoter holding suggests a long-term commitment to the company’s growth strategy, which can bolster investor confidence in the company’s future prospects.
Outlook, Risks, and Final Insight
Looking ahead, Esab India Ltd is well-positioned to capitalize on growth opportunities in the welding equipment sector, driven by increasing industrial activity and infrastructure development in India. However, potential risks include fluctuations in raw material prices and global supply chain disruptions, which could impact profitability. The company’s historical performance demonstrates resilience, but maintaining margins in a competitive landscape will be crucial. If Esab India can effectively navigate these challenges, it may continue to deliver strong returns. Conversely, failure to manage costs or adapt to market changes could hinder growth. Overall, the company’s fundamentals remain robust, suggesting a positive long-term outlook contingent on strategic execution.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Esab India Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| GEE Ltd | 442 Cr. | 85.0 | 97.9/55.2 | 37.2 | 0.00 % | 1.09 % | 4.65 % | 2.00 | |
| D&H India Ltd | 126 Cr. | 153 | 274/120 | 22.0 | 57.4 | 0.00 % | 13.5 % | 11.6 % | 10.0 |
| Esab India Ltd | 7,525 Cr. | 4,888 | 6,571/4,130 | 43.8 | 235 | 1.33 % | 70.0 % | 52.3 % | 10.0 |
| Ador Welding Ltd | 1,877 Cr. | 1,078 | 1,380/777 | 33.9 | 283 | 1.86 % | 20.3 % | 13.9 % | 10.0 |
| Industry Average | 2,492.50 Cr | 1,551.00 | 33.23 | 153.15 | 0.80% | 26.22% | 20.61% | 8.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 243 | 277 | 267 | 302 | 298 | 303 | 301 | 341 | 330 | 339 | 337 | 368 | 352 |
| Expenses | 208 | 233 | 219 | 245 | 240 | 249 | 248 | 279 | 268 | 277 | 282 | 302 | 293 |
| Operating Profit | 36 | 45 | 48 | 57 | 58 | 54 | 54 | 62 | 62 | 61 | 55 | 66 | 59 |
| OPM % | 15% | 16% | 18% | 19% | 19% | 18% | 18% | 18% | 19% | 18% | 16% | 18% | 17% |
| Other Income | 2 | 1 | 3 | 3 | 3 | 2 | 1 | 1 | 1 | 1 | 3 | 2 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Depreciation | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 3 | 4 | 4 | 4 | 4 |
| Profit before tax | 34 | 43 | 49 | 56 | 57 | 52 | 51 | 60 | 60 | 59 | 55 | 63 | 55 |
| Tax % | 25% | 26% | 25% | 26% | 25% | 26% | 26% | 26% | 26% | 27% | 26% | 24% | 26% |
| Net Profit | 26 | 32 | 36 | 42 | 42 | 38 | 38 | 44 | 44 | 43 | 40 | 47 | 41 |
| EPS in Rs | 16.63 | 20.73 | 23.59 | 27.19 | 27.53 | 24.95 | 24.65 | 28.75 | 28.88 | 28.04 | 26.23 | 30.81 | 26.60 |
Last Updated: August 20, 2025, 11:05 am
Below is a detailed analysis of the quarterly data for Esab India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 352.00 Cr.. The value appears to be declining and may need further review. It has decreased from 368.00 Cr. (Mar 2025) to 352.00 Cr., marking a decrease of 16.00 Cr..
- For Expenses, as of Jun 2025, the value is 293.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 302.00 Cr. (Mar 2025) to 293.00 Cr., marking a decrease of 9.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 59.00 Cr.. The value appears to be declining and may need further review. It has decreased from 66.00 Cr. (Mar 2025) to 59.00 Cr., marking a decrease of 7.00 Cr..
- For OPM %, as of Jun 2025, the value is 17.00%. The value appears to be declining and may need further review. It has decreased from 18.00% (Mar 2025) to 17.00%, marking a decrease of 1.00%.
- For Other Income, as of Jun 2025, the value is 1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2.00 Cr. (Mar 2025) to 1.00 Cr., marking a decrease of 1.00 Cr..
- For Interest, as of Jun 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 55.00 Cr.. The value appears to be declining and may need further review. It has decreased from 63.00 Cr. (Mar 2025) to 55.00 Cr., marking a decrease of 8.00 Cr..
- For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 24.00% (Mar 2025) to 26.00%, marking an increase of 2.00%.
- For Net Profit, as of Jun 2025, the value is 41.00 Cr.. The value appears to be declining and may need further review. It has decreased from 47.00 Cr. (Mar 2025) to 41.00 Cr., marking a decrease of 6.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 26.60. The value appears to be declining and may need further review. It has decreased from 30.81 (Mar 2025) to 26.60, marking a decrease of 4.21.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 5:23 am
| Metric | Dec 2013 | Mar 2015n n 15m | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 434 | 552 | 451 | 466 | 543 | 672 | 698 | 681 | 896 | 1,091 | 1,243 | 1,373 | 1,396 |
| Expenses | 383 | 507 | 406 | 422 | 491 | 593 | 601 | 598 | 775 | 904 | 1,014 | 1,129 | 1,154 |
| Operating Profit | 51 | 45 | 45 | 44 | 52 | 79 | 97 | 83 | 121 | 187 | 229 | 245 | 242 |
| OPM % | 12% | 8% | 10% | 9% | 10% | 12% | 14% | 12% | 13% | 17% | 18% | 18% | 17% |
| Other Income | 8 | -0 | 6 | 4 | 11 | 16 | 14 | 11 | 5 | 8 | 6 | 8 | 7 |
| Interest | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 1 | 0 | 2 | 2 | 2 |
| Depreciation | 11 | 14 | 10 | 10 | 10 | 11 | 13 | 12 | 11 | 12 | 14 | 15 | 16 |
| Profit before tax | 47 | 31 | 41 | 38 | 53 | 84 | 97 | 81 | 114 | 182 | 220 | 236 | 231 |
| Tax % | 30% | 23% | 31% | 29% | 29% | 32% | 27% | 26% | 26% | 26% | 26% | 26% | |
| Net Profit | 33 | 24 | 28 | 27 | 37 | 58 | 71 | 59 | 84 | 136 | 163 | 175 | 172 |
| EPS in Rs | 21.52 | 15.36 | 18.41 | 17.45 | 24.13 | 37.41 | 46.39 | 38.52 | 54.77 | 88.14 | 105.88 | 113.96 | 111.68 |
| Dividend Payout % | 5% | 7% | 5% | 6% | 4% | 241% | 151% | 114% | 110% | 88% | 81% | 79% |
YoY Net Profit Growth
| Year | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -3.57% | 37.04% | 56.76% | 22.41% | -16.90% | 42.37% | 61.90% | 19.85% | 7.36% |
| Change in YoY Net Profit Growth (%) | 0.00% | 40.61% | 19.72% | -34.34% | -39.32% | 59.27% | 19.53% | -42.05% | -12.49% |
Esab India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2016-2017 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 15% |
| 3 Years: | 15% |
| TTM: | 10% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 20% |
| 3 Years: | 28% |
| TTM: | 4% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 25% |
| 5 Years: | 29% |
| 3 Years: | 13% |
| 1 Year: | -15% |
| Return on Equity | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | 43% |
| 3 Years: | 54% |
| Last Year: | 52% |
Last Updated: September 5, 2025, 3:40 am
Balance Sheet
Last Updated: June 16, 2025, 12:11 pm
| Month | Dec 2013 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 |
| Reserves | 252 | 274 | 300 | 327 | 363 | 251 | 322 | 244 | 229 | 245 | 291 | 346 |
| Borrowings | 0 | 0 | 0 | 1 | 0 | 0 | 5 | 3 | 3 | 4 | 5 | 4 |
| Other Liabilities | 83 | 80 | 70 | 85 | 102 | 112 | 116 | 126 | 189 | 210 | 240 | 282 |
| Total Liabilities | 350 | 369 | 386 | 428 | 480 | 379 | 458 | 388 | 436 | 474 | 551 | 647 |
| Fixed Assets | 96 | 83 | 78 | 76 | 80 | 83 | 86 | 90 | 90 | 95 | 125 | 136 |
| CWIP | 3 | 1 | 5 | 7 | 8 | 3 | 7 | 3 | 3 | 20 | 4 | 9 |
| Investments | 105 | 122 | 120 | 147 | 125 | 30 | 70 | 41 | 31 | 0 | 0 | 24 |
| Other Assets | 147 | 163 | 183 | 198 | 269 | 262 | 295 | 255 | 312 | 359 | 421 | 478 |
| Total Assets | 350 | 369 | 386 | 428 | 480 | 379 | 458 | 388 | 436 | 474 | 551 | 647 |
Below is a detailed analysis of the balance sheet data for Esab India Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 15.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 15.00 Cr..
- For Reserves, as of Mar 2025, the value is 346.00 Cr.. The value appears strong and on an upward trend. It has increased from 291.00 Cr. (Mar 2024) to 346.00 Cr., marking an increase of 55.00 Cr..
- For Borrowings, as of Mar 2025, the value is 4.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 5.00 Cr. (Mar 2024) to 4.00 Cr., marking a decrease of 1.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 282.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 240.00 Cr. (Mar 2024) to 282.00 Cr., marking an increase of 42.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 647.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 551.00 Cr. (Mar 2024) to 647.00 Cr., marking an increase of 96.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 136.00 Cr.. The value appears strong and on an upward trend. It has increased from 125.00 Cr. (Mar 2024) to 136.00 Cr., marking an increase of 11.00 Cr..
- For CWIP, as of Mar 2025, the value is 9.00 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Mar 2024) to 9.00 Cr., marking an increase of 5.00 Cr..
- For Investments, as of Mar 2025, the value is 24.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 24.00 Cr., marking an increase of 24.00 Cr..
- For Other Assets, as of Mar 2025, the value is 478.00 Cr.. The value appears strong and on an upward trend. It has increased from 421.00 Cr. (Mar 2024) to 478.00 Cr., marking an increase of 57.00 Cr..
- For Total Assets, as of Mar 2025, the value is 647.00 Cr.. The value appears strong and on an upward trend. It has increased from 551.00 Cr. (Mar 2024) to 647.00 Cr., marking an increase of 96.00 Cr..
Notably, the Reserves (346.00 Cr.) exceed the Borrowings (4.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Dec 2013 | Mar 2015n n 15m | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 51.00 | 45.00 | 45.00 | 43.00 | 52.00 | 79.00 | 92.00 | 80.00 | 118.00 | 183.00 | 224.00 | 241.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Dec 2013 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 23 | 29 | 37 | 37 | 40 | 35 | 44 | 53 | 55 | 51 | 55 | 60 |
| Inventory Days | 82 | 55 | 76 | 77 | 76 | 58 | 66 | 61 | 68 | 67 | 55 | 59 |
| Days Payable | 70 | 56 | 56 | 71 | 78 | 71 | 74 | 80 | 93 | 82 | 65 | 87 |
| Cash Conversion Cycle | 35 | 28 | 57 | 43 | 38 | 21 | 36 | 34 | 30 | 36 | 45 | 31 |
| Working Capital Days | 18 | 22 | 39 | 34 | 67 | 48 | 40 | 46 | 30 | 30 | 25 | 26 |
| ROCE % | 19% | 15% | 14% | 13% | 15% | 26% | 32% | 27% | 44% | 71% | 77% | 70% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| SBI Small Cap Fund | 900,000 | 2.47 | 521.37 | 900,000 | 2025-04-22 14:12:25 | 0% |
| Nippon India Small Cap Fund | 326,882 | 0.51 | 189.36 | 326,882 | 2025-04-22 15:56:58 | 0% |
| SBI Magnum Global Fund | 250,000 | 2.37 | 144.82 | 250,000 | 2025-04-22 15:56:58 | 0% |
| SBI Contra Fund | 150,000 | 0.52 | 86.89 | 150,000 | 2025-04-22 15:56:58 | 0% |
| SBI Infrastructure Fund | 78,374 | 3.47 | 45.4 | 78,374 | 2025-04-22 15:56:58 | 0% |
| SBI Retirement Benefit Fund - Aggressive Plan | 43,850 | 1.44 | 25.4 | 43,850 | 2025-04-22 15:56:58 | 0% |
| SBI Retirement Benefit Fund - Aggressive Hybrid Plan | 42,100 | 2.18 | 24.39 | 42,100 | 2025-04-22 15:56:58 | 0% |
| SBI Conservative Hybrid Fund | 41,177 | 0.27 | 23.85 | 41,177 | 2025-04-22 15:56:58 | 0% |
| SBI Conservative Hybrid Fund - Div (Annual) | 41,177 | 0.27 | 23.85 | 41,177 | 2025-04-22 15:56:58 | 0% |
| SBI Conservative Hybrid Fund - Div (Monthly) | 41,177 | 0.27 | 23.85 | 41,177 | 2025-04-22 15:56:58 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 113.98 | 105.90 | 88.16 | 54.78 | 38.52 |
| Diluted EPS (Rs.) | 113.98 | 105.90 | 88.16 | 54.78 | 38.52 |
| Cash EPS (Rs.) | 123.68 | 114.86 | 95.88 | 62.14 | 46.13 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 234.73 | 198.87 | 169.12 | 158.69 | 168.43 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 234.73 | 198.87 | 169.12 | 158.69 | 168.43 |
| Dividend / Share (Rs.) | 90.00 | 86.00 | 78.00 | 60.00 | 44.00 |
| Revenue From Operations / Share (Rs.) | 892.44 | 807.88 | 708.77 | 580.12 | 444.84 |
| PBDIT / Share (Rs.) | 163.95 | 152.16 | 126.37 | 81.34 | 60.20 |
| PBIT / Share (Rs.) | 154.26 | 143.20 | 118.65 | 73.98 | 52.59 |
| PBT / Share (Rs.) | 153.16 | 142.92 | 118.45 | 73.79 | 52.33 |
| Net Profit / Share (Rs.) | 113.98 | 105.90 | 88.16 | 54.78 | 38.52 |
| PBDIT Margin (%) | 18.37 | 18.83 | 17.82 | 14.02 | 13.53 |
| PBIT Margin (%) | 17.28 | 17.72 | 16.74 | 12.75 | 11.82 |
| PBT Margin (%) | 17.16 | 17.69 | 16.71 | 12.71 | 11.76 |
| Net Profit Margin (%) | 12.77 | 13.10 | 12.43 | 9.44 | 8.66 |
| Return on Networth / Equity (%) | 48.55 | 53.25 | 52.13 | 34.52 | 22.87 |
| Return on Capital Employeed (%) | 63.68 | 69.55 | 67.53 | 45.42 | 30.41 |
| Return On Assets (%) | 27.10 | 29.57 | 28.62 | 19.33 | 15.27 |
| Asset Turnover Ratio (%) | 2.29 | 2.43 | 2.40 | 2.17 | 1.62 |
| Current Ratio (X) | 1.74 | 1.75 | 1.72 | 1.81 | 2.39 |
| Quick Ratio (X) | 1.26 | 1.27 | 1.12 | 1.25 | 1.78 |
| Inventory Turnover Ratio (X) | 11.35 | 4.85 | 4.59 | 4.95 | 4.09 |
| Dividend Payout Ratio (NP) (%) | 68.43 | 71.78 | 88.49 | 118.66 | 231.06 |
| Dividend Payout Ratio (CP) (%) | 63.07 | 66.18 | 81.37 | 104.61 | 192.95 |
| Earning Retention Ratio (%) | 31.57 | 28.22 | 11.51 | -18.66 | -131.06 |
| Cash Earning Retention Ratio (%) | 36.93 | 33.82 | 18.63 | -4.61 | -92.95 |
| Interest Coverage Ratio (X) | 150.19 | 557.55 | 627.35 | 431.66 | 225.98 |
| Interest Coverage Ratio (Post Tax) (X) | 105.42 | 389.05 | 438.68 | 291.72 | 145.61 |
| Enterprise Value (Cr.) | 6919.71 | 8003.20 | 5385.84 | 4620.73 | 2719.72 |
| EV / Net Operating Revenue (X) | 5.04 | 6.44 | 4.94 | 5.18 | 3.97 |
| EV / EBITDA (X) | 27.42 | 34.18 | 27.69 | 36.91 | 29.35 |
| MarketCap / Net Operating Revenue (X) | 5.10 | 6.51 | 4.99 | 5.23 | 4.03 |
| Retention Ratios (%) | 31.56 | 28.21 | 11.50 | -18.66 | -131.06 |
| Price / BV (X) | 19.37 | 26.44 | 20.91 | 19.10 | 10.65 |
| Price / Net Operating Revenue (X) | 5.10 | 6.51 | 4.99 | 5.23 | 4.03 |
| EarningsYield | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 |
After reviewing the key financial ratios for Esab India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 113.98. This value is within the healthy range. It has increased from 105.90 (Mar 24) to 113.98, marking an increase of 8.08.
- For Diluted EPS (Rs.), as of Mar 25, the value is 113.98. This value is within the healthy range. It has increased from 105.90 (Mar 24) to 113.98, marking an increase of 8.08.
- For Cash EPS (Rs.), as of Mar 25, the value is 123.68. This value is within the healthy range. It has increased from 114.86 (Mar 24) to 123.68, marking an increase of 8.82.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 234.73. It has increased from 198.87 (Mar 24) to 234.73, marking an increase of 35.86.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 234.73. It has increased from 198.87 (Mar 24) to 234.73, marking an increase of 35.86.
- For Dividend / Share (Rs.), as of Mar 25, the value is 90.00. This value exceeds the healthy maximum of 3. It has increased from 86.00 (Mar 24) to 90.00, marking an increase of 4.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 892.44. It has increased from 807.88 (Mar 24) to 892.44, marking an increase of 84.56.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 163.95. This value is within the healthy range. It has increased from 152.16 (Mar 24) to 163.95, marking an increase of 11.79.
- For PBIT / Share (Rs.), as of Mar 25, the value is 154.26. This value is within the healthy range. It has increased from 143.20 (Mar 24) to 154.26, marking an increase of 11.06.
- For PBT / Share (Rs.), as of Mar 25, the value is 153.16. This value is within the healthy range. It has increased from 142.92 (Mar 24) to 153.16, marking an increase of 10.24.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 113.98. This value is within the healthy range. It has increased from 105.90 (Mar 24) to 113.98, marking an increase of 8.08.
- For PBDIT Margin (%), as of Mar 25, the value is 18.37. This value is within the healthy range. It has decreased from 18.83 (Mar 24) to 18.37, marking a decrease of 0.46.
- For PBIT Margin (%), as of Mar 25, the value is 17.28. This value is within the healthy range. It has decreased from 17.72 (Mar 24) to 17.28, marking a decrease of 0.44.
- For PBT Margin (%), as of Mar 25, the value is 17.16. This value is within the healthy range. It has decreased from 17.69 (Mar 24) to 17.16, marking a decrease of 0.53.
- For Net Profit Margin (%), as of Mar 25, the value is 12.77. This value exceeds the healthy maximum of 10. It has decreased from 13.10 (Mar 24) to 12.77, marking a decrease of 0.33.
- For Return on Networth / Equity (%), as of Mar 25, the value is 48.55. This value is within the healthy range. It has decreased from 53.25 (Mar 24) to 48.55, marking a decrease of 4.70.
- For Return on Capital Employeed (%), as of Mar 25, the value is 63.68. This value is within the healthy range. It has decreased from 69.55 (Mar 24) to 63.68, marking a decrease of 5.87.
- For Return On Assets (%), as of Mar 25, the value is 27.10. This value is within the healthy range. It has decreased from 29.57 (Mar 24) to 27.10, marking a decrease of 2.47.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 2.29. It has decreased from 2.43 (Mar 24) to 2.29, marking a decrease of 0.14.
- For Current Ratio (X), as of Mar 25, the value is 1.74. This value is within the healthy range. It has decreased from 1.75 (Mar 24) to 1.74, marking a decrease of 0.01.
- For Quick Ratio (X), as of Mar 25, the value is 1.26. This value is within the healthy range. It has decreased from 1.27 (Mar 24) to 1.26, marking a decrease of 0.01.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 11.35. This value exceeds the healthy maximum of 8. It has increased from 4.85 (Mar 24) to 11.35, marking an increase of 6.50.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 68.43. This value exceeds the healthy maximum of 50. It has decreased from 71.78 (Mar 24) to 68.43, marking a decrease of 3.35.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 63.07. This value exceeds the healthy maximum of 50. It has decreased from 66.18 (Mar 24) to 63.07, marking a decrease of 3.11.
- For Earning Retention Ratio (%), as of Mar 25, the value is 31.57. This value is below the healthy minimum of 40. It has increased from 28.22 (Mar 24) to 31.57, marking an increase of 3.35.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 36.93. This value is below the healthy minimum of 40. It has increased from 33.82 (Mar 24) to 36.93, marking an increase of 3.11.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 150.19. This value is within the healthy range. It has decreased from 557.55 (Mar 24) to 150.19, marking a decrease of 407.36.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 105.42. This value is within the healthy range. It has decreased from 389.05 (Mar 24) to 105.42, marking a decrease of 283.63.
- For Enterprise Value (Cr.), as of Mar 25, the value is 6,919.71. It has decreased from 8,003.20 (Mar 24) to 6,919.71, marking a decrease of 1,083.49.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 5.04. This value exceeds the healthy maximum of 3. It has decreased from 6.44 (Mar 24) to 5.04, marking a decrease of 1.40.
- For EV / EBITDA (X), as of Mar 25, the value is 27.42. This value exceeds the healthy maximum of 15. It has decreased from 34.18 (Mar 24) to 27.42, marking a decrease of 6.76.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 5.10. This value exceeds the healthy maximum of 3. It has decreased from 6.51 (Mar 24) to 5.10, marking a decrease of 1.41.
- For Retention Ratios (%), as of Mar 25, the value is 31.56. This value is within the healthy range. It has increased from 28.21 (Mar 24) to 31.56, marking an increase of 3.35.
- For Price / BV (X), as of Mar 25, the value is 19.37. This value exceeds the healthy maximum of 3. It has decreased from 26.44 (Mar 24) to 19.37, marking a decrease of 7.07.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 5.10. This value exceeds the healthy maximum of 3. It has decreased from 6.51 (Mar 24) to 5.10, marking a decrease of 1.41.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Esab India Ltd:
- Net Profit Margin: 12.77%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 63.68% (Industry Average ROCE: 26.22%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 48.55% (Industry Average ROE: 20.61%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 105.42
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.26
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 43.8 (Industry average Stock P/E: 33.23)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 12.77%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Welding Equipments | Plot No.13, 3rd Main Road, Industrial Estate, Chennai (Madras) Tamil Nadu 600058 | investor.relations@esab.co.in http://www.esabindia.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Kevin J Johnson | Chairman |
| Mr. Rohit Gambhir | Managing Director |
| Mr. B Mohan | Director & CFO |
| Ms. Cauvery Dharmaraj | Independent Director |
| Mr. N Ramesh Rajan | Independent Director |
| Mr. Raja Venkataraman | Independent Director |
FAQ
What is the intrinsic value of Esab India Ltd?
Esab India Ltd's intrinsic value (as of 04 November 2025) is 4363.87 which is 10.72% lower the current market price of 4,888.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 7,525 Cr. market cap, FY2025-2026 high/low of 6,571/4,130, reserves of ₹346 Cr, and liabilities of 647 Cr.
What is the Market Cap of Esab India Ltd?
The Market Cap of Esab India Ltd is 7,525 Cr..
What is the current Stock Price of Esab India Ltd as on 04 November 2025?
The current stock price of Esab India Ltd as on 04 November 2025 is 4,888.
What is the High / Low of Esab India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Esab India Ltd stocks is 6,571/4,130.
What is the Stock P/E of Esab India Ltd?
The Stock P/E of Esab India Ltd is 43.8.
What is the Book Value of Esab India Ltd?
The Book Value of Esab India Ltd is 235.
What is the Dividend Yield of Esab India Ltd?
The Dividend Yield of Esab India Ltd is 1.33 %.
What is the ROCE of Esab India Ltd?
The ROCE of Esab India Ltd is 70.0 %.
What is the ROE of Esab India Ltd?
The ROE of Esab India Ltd is 52.3 %.
What is the Face Value of Esab India Ltd?
The Face Value of Esab India Ltd is 10.0.